Table 1 Clinical characteristics of patients included into the study
From: MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation
Variable | N = 77 (100%) | ||
|---|---|---|---|
Disease | MM: 54 (70.1) HL: 11 (14.3) MCL: 5 (6.5) DLBCL: 3 (3.9) Other: 4 (5.2) | ||
Conditioning regimen | Mel-200: 39 (50.6) Reduced Mel: 16 (20.8) BeEAM: 17 (22.1) BEAM: 5 (6.5) | ||
Variable | MM | ML | p |
Sex | F: 29 (53.7) M: 25 (46.3) | F: 11 (47.8) M: 12 (52.2) | 0.8233 |
Age at AHSCT Median (25–75%), years | 61.3 (53.8–66.4) | 47.4 (39.5–54.1) | < 0.0001 |
Number of CD34 + cells transplanted (× 106 cells/kg) Median (25–75%) | 3.9 (3.1–5.3) | 4.6 (3.3–5.7) | 0.4092 |
Mucositis- any grade | 34 (64.2) | 23 (100.0) | 0.0004 |
Mucositis– grade ≥ 2 | 18 (34.0) | 22 (95.7) | < 0.0001 |
Bacteremia | 11 (20.4) | 8 (34.8) | 0.2920 |
Neutropenic fever | 30 (58.8) | 18 (78.3) | 0.1745 |
Days to PLT engraftment Median (25–75%) | 10 (10–13) | 15 (12–18) | 0.0001 |
Days to ANC engraftment Median (25–75%) | 11 | 10 | 0.0299 |